Back Leukemie Afrikaans Leucemia AN ابيضاض الدم Arabic لوكيميا ARZ লিউকিমিয়া Assamese Leucemia AST Leykoz Azerbaijani قان سرطانی AZB Leukemėjė BAT-SMG Лейкоз Byelorussian

Sankaran Bargo (Leukemia)

Sankaran Bargo
Description (en) Fassara
Iri hematologic cancer (en) Fassara, myeloproliferative disorders (en) Fassara
cuta
Field of study (en) Fassara hematology (en) Fassara
Symptoms and signs (en) Fassara bone pain (en) Fassara, Jiri, weight loss (en) Fassara, chest pain (en) Fassara, Kumburi
angina pectoris (en) Fassara
Medical treatment (en) Fassara
Magani methotrexate (en) Fassara, cytarabine (en) Fassara, vincristine (en) Fassara, pipobroman (en) Fassara, irinotecan (en) Fassara, isotretinoin (en) Fassara, doxorubicin hydrochloride (en) Fassara, (RS)-lenalidomide (en) Fassara, nilotinib (en) Fassara, dasatinib monohydrate (en) Fassara, ibrutinib (en) Fassara, ruxolitinib (en) Fassara, imatinib (en) Fassara, bosutinib (en) Fassara da rituximab (en) Fassara
Identifier (en) Fassara
ICD-10-CM C95.90, C95 da C95.9
ICD-9-CM 208, 208.9, 207.8, 208.80, 207, 208.90, 207.80 da 208.8
ICD-O: 9800, 980-994 da 980
DiseasesDB 7431
MedlinePlus 001299
eMedicine 001299
MeSH D007938
Disease Ontology ID DOID:1240

Leukemia (Hakanan an rubuta cutar sankara da haruffan /l uː ˈk iː m iːə / loo-KEE -mee-ə ) ya kasance wani rukuni ne na cututtukan daji na jini wanda yawanci ke farawa a cikin`kasusuwa kuma yana haifar da adadi mai yawa na kwayoyin jini marasa al'ada. .[1] Wadannan kwayoyin jini ba su cika habaka ba kuma ana kiran su blasts ko kwayoyin cutar sankara [2] Alamu na iya hadawa da zub da jini da barna, ciwon Kashi, gajiya, zazzabi, da kara hadarin cututtuka.[3] Wadannan alamun suna faruwa ne saboda rashin kwayoyin jini na al'ada. [2] Ana ganewa su ta asalin hanyar gwaje-gwajen jini ko kwayar dake cikin kasusuwa. [2]

Ba a san ainihin dalilin cutar sankara ba. [4] Hadin abubuwan kwayoyin halitta da abubuwan muhalli (marasa kyau) an yi imanin hakan kuma yana taka rawa.[4] Abubuwan hadari sun hada da shan taba, ionizing radiation, wasu sinadarai (irin su benzene ), kafin chemotherapy, da Down syndrome . [4][5] Mutanen da ke da gadon cutar sankara su ma suna cikin hadari mafi girma. [5] Akwai manyan nau'ukan cutar sankara guda hudu - m lymphoblastic leukemia (ALL), m myeloid leukemia (AML), cutar sankara ta lymphocytic na yau da kullun (CLL) da cutar sankara ta myeloid (CML) - da kuma nau'ikan da ba su da yawa.[5][6] Cutar sankara da lymphomas duka suna cikin rukunin da ke shafar jini, kasusuwa, da tsarin lymphoid, wadanda aka sani da kwayoyin hematopoietic da lymphoid .[7][8]

chemotherapy, farfesan ban garen magani, da kuma dashen kasusuwa, ban da kulawa da tallafi kamar yadda ake bukata. [9] Ana iya sarrafa wasu nau'ikan cutar sankara tare da jira a hankali. [5] Nasarar jinya ya dogara da nau'in cutar sankara da shekarun mutum. Sakamako ya inganta a kasashen da suka ci gaba.[6] Yawan rayuwa na shekaru biyar shi ne 57% a Amurka.[10] A cikin yara 'yan ƙasa da 15, adadin rayuwa na shekaru biyar ya fi 60% ko ma 90%, ya danganta da nau'in cutar sankara.[11] A cikin yara masu fama da cutar sankara waɗanda ba su da kansa bayan shekaru biyar, da wuya ciwon daji ya dawo .[11]

A cikin 2015, cutar sankara ta kasance a cikin mutane miliyan 2.3 a duk duniya kuma ta haifar da mutuwar muta ne sama da 353,500.[12][13] A cikin 2012 cutar ta fara haɓakawa a cikin mutane 352,000.[6] Shi ne mafi yawan nau'in ciwon daji a cikin yara, tare da kashi uku cikin hudu na cutar sankara a cikin yara shine nau'in lymphoblastic kuma mai tsanani. Duk da haka, fiye da kashi 90 cikin 100 na duk cutar sankara ana gano su a cikin manya, tare da CLL da AML sun fi yawa a cikin manya.[5][14] Ya kuma fi faruwa a kasashen da suka ci gaba .[6]

  1. ↑ "Leukemia". NCI. 1 January 1980. Archived from the original on 27 May 2014. Retrieved 13 June 2014. Cancer that starts in blood-forming tissue, such as the bone marrow, and causes large numbers of abnormal blood cells
  2. ↑ 2.0 2.1 2.2 Empty citation (help)
  3. ↑ "What You Need To Know About™ Leukemia". National Cancer Institute. 23 December 2013. Archived from the original on 6 July 2014. Retrieved 18 June 2014.
  4. ↑ 4.0 4.1 4.2 Hutter, JJ (Jun 2010). "Childhood leukemia". Pediatrics in Review. 31 (6): 234–41. doi:10.1542/pir.31-6-234. PMID 20516235.
  5. ↑ 5.0 5.1 5.2 5.3 5.4 Empty citation (help)
  6. ↑ 6.0 6.1 6.2 6.3 World Cancer Report 2014. World Health Organization. 2014. pp. Chapter 5.13. ISBN 978-9283204299.
  7. ↑ Vardiman, JW; Thiele, J; Arber, DA; Brunning, RD; Borowitz, MJ; Porwit, A; Harris, NL; Le Beau, MM; Hellström-Lindberg, E; Tefferi, A; Bloomfield, CD (30 July 2009). "The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes". Blood. 114 (5): 937–51. doi:10.1182/blood-2009-03-209262. PMID 19357394. S2CID 3101472.
  8. ↑ Cătoi, Alecsandru Ioan Baba, Cornel (2007). Comparative oncology. Bucharest: The Publishing House of the Romanian Academy. p. Chapter 17. ISBN 978-973-27-1457-7. Archived from the original on 10 September 2017.
  9. ↑ Cordo V, Meijerink J (January 2021). "T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies". Blood Cancer Discovery. 2 (1): 19–31. doi:10.1158/2643-3230.BCD-20-0093. ISSN 2643-3230. PMC 8447273 Check |pmc= value (help). PMID 34661151 Check |pmid= value (help).
  10. ↑ "SEER Stat Fact Sheets: Leukemia". National Cancer Institute. 2011. Archived from the original on 16 July 2016.
  11. ↑ 11.0 11.1 American Cancer Society (2 March 2014). "Survival rates for childhood leukemia". Archived from the original on 14 July 2014.
  12. ↑ GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (8 October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
  13. ↑ GBD 2015 Mortality and Causes of Death, Collaborators. (8 October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
  14. ↑ "Chronic Lymphocytic Leukemia (CLL) - Hematology and Oncology". MSD Manual Professional Edition (in Turanci). Retrieved 2020-02-01.
From Wikipedia, the free encyclopedia · View on Wikipedia

Developed by Nelliwinne